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Summary.-256 Wistar rats received a single injection into the right pleural cavity
of UICC crocidolite in order to induce mesotheliomas. They were then given right
intrapleural injections of BCG, crystalline silica, talc, carrageenan or saline (as a
control). There was no significant change in the mesothelioma rate in the rats exposed
to BCG, silica or talc, but there was a 3-fold increase in mesothelioma incidence
in the group injected with carrageenan.
MESOTHELIOMAS are readily produced
in rats by the intrapleural inoculation of
asbestos (XVagner et al., 1973). The ex-
periments described in this paper were
carried out to test whether the rate of
induction of mesotheliomas could be
altered by various secondary treatments.
It was hoped by this exploration to find
means of delaying tuimour induction and
thus possibly reducing the incidence. At
present only sham thymectomy during the
first 4 days after birth has been shown to
reduce the number of mesotheliomas in-
duced by the asbestos (Wagner, 1979).
This paper explores the role played by
some of the substances which destroy or
alter the function of macrophages.
The role of macrophages in the develop-
ment of asbestos-induced pleural meso-
theliomas is unknown. In serial killings it
was found that neoplastic growth initially
appeared at the periphery of fibre-con-
taining granulomas. From personal obser-
vations (J. C. WVagner) it appeared that
when tumours first appeared, the number
of macrophages in the granulomas was
greatly reduced. Perhaps the decreased
number of phagocytic cells might effect
initiation of the tumour, as well as rejec-
tion of tumour cells. We decided, there-
fore, to introduce the treatments before
tumour development.
MATERIALS AND METHODS
The experimental animals w-ere barrier-
protected Caesarian-derived rats of the
Wistar strain, bred at the Pneumoconiosis
Unit from a stock donated by Imperial
Chemical Industries, Pharmaceutical Divi-
sion, Alderley Edge, Cheshire in 1968. A total
of 256 rats was used. These wAere in 7 batches
introduced into the experiment as available
over a 2-year period betwAeen March 1972
and March 1974 (Table I).
The asbestos used was the UICC standard
reference sample of crocidolite (Timbrell
et al., 1968). The sample wAas suspended in
physiological saline (50 mg/ml). The dose was
20 mg per rat injected into the right pleural
cavity, using the technique described by
Wagner & Berry (1969). After injection, rats
were kept 4 to a cage isolated in a special
unit and fed on a proprietary brand of auto-
claved cubes with wvater ad libitum.
Several months after the injection of croci-
dolite asbestos, a course of supplementary
treatment was started on somerats, with other
rats left untreated as controls. So that
variation between the batches would not
affect the assessment of the supplementary
treatments, the experiment was designed so
that all comparisons were Awithin batches;
that is, rats in half the cages wvere given the
supplementary treatment and rats in the
other half wNere left untreated (or in Batch 6
the rats were divided into 3 groups). As far as
possible within the limitations of caging, the
sexes were equally distributed over theTREATMENT OF EXPERIMENTAL MESOTHELIOMAS
TABLE I.-Schedule ofinjections
No. ofrats
Batch d V
1 0 24
2 12 12
3 12 12
4 0 24
5 12 12
6 40 48
7 24 24
Age at
crocidolite
injection
(weeks)
13
7
11
8-10
9
9-10
10
supplementary treatments; the slight im-
balance is of little consequence, since earlier
experiments had shown that sex is unimpor-
tant to mesothelioma induction (Wagner &
Berry, 1969; Wagner et al., 1973).
The following substances were used for
secondary treatment:
Batches 1-5.-BCG, Glaxo freeze-dried
(Dr M. Pimm, Cancer Research Laboratories,
Nottingham). It was rendered non-viable by
irradiation with 106 rad and then made up
with saline to 10 mg/ml. Five batches of 24
animals each were divided equally, half
receiving BCG, halfsaline. Each batch started
treatment at a different time (Table I).
Each rat undergoing BCG treatment was
given a pre-sensitizing dose of 041 mg in the
footpad followed by 0-1 mg intrapleurally,
then 1 mg intrapleurally at varying intervals;
Batches 1 and 2 received 3 doses of 1 mg
weekly, 2 doses of 1 mg at 2-week intervals,
2 monthly doses of 1 mg and finally, 0-2 mg
monthly for 3 months, giving a total dose of
7-8 mg/rat. Batches 3, 4 and 5, after sensitiza-
tion, received 5 monthly doses of 1 mg, giving
a total BCG dose of 5-2 mg.
Batch 6.-Silica, Min-U-Sil. A crystalline
silica ofsize range <0-1-46 ,um (Wagneretal.,
submitted forpublication) at 20 mg in a single
dose.
Cartageenan (Marine Colloids HMR RE6
326-3) 10 mg initially with additional doses
of 10 mg, 8 and 9 months later for rats still
alive.
In order to test the reaction to the carra-
62
Supplementary
treatment
BCG
BCG
BCG
BCG
BCG
Silica
Carrageenan
Saline
Saline
Talc
No. ofrats
0 12
0 12
4 8
8 4
8 4
4 8
0 12
0 12
8 4
4 8
12 16
12 16
8 8
8 8
12 12
12 12
Period after
crocidolite
(months)
17
15
13
10
7
8
12
8
12
13
geenan alone, a preliminary study was carried
out in which 12 rats, aged about 14 months,
were inoculated with 10 mg intrapleurally.
One of these animals was killed 3 days after
injection, another after 2 weeks, 2 after 7
weeks and the remaining 8 after 5 months.
Sections from the right visceral pleura in the
first animal showed a significant prolifera-
tion of the mesothelial cells, in the second
animal only a few mesothelial cells appeared
distended, and occasional foamymacrophages
were seen in the sinuses ofthe draining lymph
glands. No significant change was seen in all
the remaining animals. It appeared, therefore,
that the reaction to a single inoculation of
carrageenan was transitory, no effect being
observed after 7 weeks. In contrast, the
mineral dusts remaining in situ produced
granulomas throughout the experiment.
Saline. One injection of equal volume to
that used for silica or the initial dose of
carrageenan.
Batch 7.-Talc, Italian talc (Code 00000).
40 mg in 2 equal doses with an 8-week interval
between doses.
All substances were autoclaved and sus-
pended in physiological saline.
Each rat was allowed to live until death,
unless it appeared to be distressed, when it
was killed by chloroform exposure. A full
necropsy examination was carried out on all
rats, except for the control in Batch 7 that
died only 2 days after asbestos injection. One
rat in Batch 7 that received talc treatment
was lost.
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RESULTS
The mean survival time, number of
mesotheliomas, and time of first meso-
thelioma are given in Table II, and the
distribution of survival times in the
Figure.
TABLE II.-Re,8ults
Supple-
Batch ment
1 -
BCG
2
BCG
3
BCG
4 -
BCG
5 -
BCG
Total
1-5 BCG
6 Saline
Silica
Carra-
geenan
7
Talc
Mean
Sur-
vival
(days)
706
663
727
693
667
680
691
714
652
588
688
668
657
641
606
592
604
No. of
meso-
thelioma/
No.
injected
4/12
6/12
6/12
3/12
5/12
2/12
2/12
1/12
2/12
2/12
19/60
14/60
14/32
15/28
20/28
9/24
7/23
Time from
injection
to first
meso-
thelioma
(days)
535
550
650
495
587
473
810
832
579
377
535
377
399
492
424
506
455
In the group in Batch 6 injected with
silica 8 months after the asbestos injection
there were 3 rats which developed a
lymphoma (Wagner & Wagner, 1972). All
3 of these also had a mesothelioma, 711,
712 and 823 days after the asbestos injec-
tion. One other rat, which did not have a
mesothelioma and died 734 days after the
asbestos injection, was noted as "? silica
injection-site tumour".
The differences in mesothelioma inci-
dence have been analysed by the con-
ditional likelihood method of Cox (1972).
This method estimates the relative inci-
dence of tumours, after making the neces-
sary allowance for mortality due to other
causes, differences in survival time, and,
in the case of the BCG effect, variation
between Batches 1-5. All rats dying before
the occurrence of the first mesothelioma
in each batch are excluded fromn the
analysis.
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FIG.-Distribution of survival times and
tumours according to treatment. O 1 rat;
* 1 rat with mesothelioma.
The time schedule ofthe BCG treatment
differed between batches, but there was
no evidence of heterogeneity between
Batches 1-5 in the size of the BCG effect.
This could have been because the separate
batches were small. Using the data from
all the batches together, the mesothelioma
incidence in the BCG-treated rats was
70% of the rate of the comparable group
(Table III); this reduction could have
been due to chance (P = 0 4). In Batch 6
TABLE III.-Analysis of supplementary
treatments
Batch Supplement
1-5 -
BCG
6 Saline
Silica
Carrageenan
7
Talc
Mesos
32
23
44
54
71
39
Relative meso
incidence
(95% limits
in brackets)
1.0
0 7 (0-4-1-5)
1.0
1.1 (0.5-2.3)
3-1 (1-5-6-5)
1-0
30 0-8 (0.3-2.3)
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the slight increase in the silica group was
not significant. The mesothelioma inci-
dence in the carrageenan group was 3 1
times that in the saline group (P < 001);
the estimated relative effect was greater
than the increase in the proportion of rats
with mesotheliomas (71% vs 440). This is
because Cox's method allowed for the 50
days' reduction in average survival in the
carrageenan group, compared with the
saline group (Table II). In Batch 7, the
slight reduction in the talc group could
also have been due to chance.
DISCUSSION
BCG therapy at the time the tumour
usually develops obviously has little
effect. Evans & Alexander (1972) have
shown that macrophages taken from an
animal sensitized to PPD, when reintro-
duced to PPD, will nonspecifically kill
tumour cells. It is of importance in the
future, therefore, to investigate whether
the tumour rate could be altered if the
first dose of BCG was given before the
intrapleural crocidolite, followed by other
doses at the time the tumour would
develop.
The differences in the results found with
silica, talc and carrageenan are interesting.
Silica (O'Rourke et al., 1978) has been
shown to kill macrophages and not
lymphocytes. Carrageenan (Allison et al.,
1966) is known to be cytotoxic towards
macrophages, whereas there is no such
evidence available for talc. Keller (1976)
has stated that carrageenan gave an
analogous or even more pronounced en-
hancement of tumour growth than silica.
It has been suggested by Allison (1976)
that silica may only temporarily deplete
macrophages. Silica was given in only one
dose in contrast to 3 doses of carrageenan,
in which the first dose was later. Accord-
ing to Keller (1976) the enhancing effects
of silica and carrageenan are "sharply
circumscribed" and only when given at
the same time as s.c. tumour cells is there
a marked enhancement of tumour growth.
The difference between silica and carra-
geenan in our experiment could then be
accounted for by the different inoculation
schedules, (carrageenan being perhaps
given at a more appropriate time) and
because carrageenan is, according to
Keller, more potent in advancing tumour
growth.
That carrageenan produced mesotheli-
omas is unlikely, as in the preliminary
study it was found that the reaction
caused by this material was transitory.
Although there is no proof that there was
no persistent reaction after the 3 injec-
tions, only fibrous dusts have been shown
to produce mesotheliomas. Previous work
has shown that silica and talc do not pro-
duce mesotheliomas after intrapleural
injection (Wagner & Wagner, 1972; Wag-
ner et al., 1977).
Ifthe work ofYung & Cudkowicz (1977)
on rejection of foreign bone grafts is
relevant to tumour rejection, the anti-
complementary effect of carrageenan
(which they have shown does not weaken
rejection) will not be the effective factor
in this instance. The depression ofimmune
responses reported by Thompson et al.
(1976) and Schwartz & Catanzaro (1973)
may also be due to the antimacrophage
effect of carrageenan.
However, in a recent evaluation of the
effects of carrageenan on macrophages in
vitro, Simon & Jones (1979) suggested that
while macrophages contained carrageenan
they remained viable and capable of
phagocytosing carbon. Yung & Cudkowicz
(1978) have proposed that carrageenan
induces transition from the pre-suppressor
to the suppressor state of a macrophage-
like cell. Moreover, this causes the failure
of generation of cytotoxic T lymphocytes
and the generation instead ofT suppressor
cells. Perhaps the different indirect action
of carrageenan on T lymphocytes may
help to account for the discrepancy we
find between carrageenan and silica.
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